Effects of Atosiban on uterine peristalsis following frozen embryo transfer: a randomized controlled trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

TCTR

Registry ID

TCTR20200608002

Enrollment

Registered

2020-06-08

Start date

2020-05-27

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

uterine peristalsis following frozen embryo transfer uterine peristalsis&#44

Interventions

Isotonic solution,antioxytocin

Placebo Comparator Drug,Active Comparator Drug

normal saline ,Atosiban

Eligibility

Sex/Gender

Female

Age

20 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1.female infertile

Exclusion criteria

Exclusion criteria: 1.female infertile had uterine anomaly, adenomyosis, uterine fiboids and endometrial polyp 2.female infertile had history of Atosiban allergy. 3.surrogate mother 4.female infertile had cardiovascular disease and asthma

Design outcomes

Primary

Measure	Time frame
uterine uterine peristalsis 30 minute before embryo transfer , 2 hr after embryo transfer tranvaginal ultrasonography	—

Secondary

Measure	Time frame
Implantation rate 2 weeks after embryo transfer number of implantation ,clinical pregnancy rate 2 weeks after embryo transfer number of pregnancy	—

Countries

thailand

Contacts

Public Contactlingling sarang

khonkaen university

linglingjill@gmail.com+66850064430

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026